<DOC>
	<DOCNO>NCT02581280</DOCNO>
	<brief_summary>Extracorporeal membrane oxygenation ( ECMO ) device increase supply oxygen body tissue vitro assist heart lung function . Venoarterial ( VA ) ECMO use patient cardiogenic shock , cardiac arrest , ventricular arrhythmia able secure time self-recovery reduce excessive stimulation apply heart . However , ECMO patient , pharmacokinetics drug change increased volume distribution ( Vd ) decrease clearance ( CL ) . For reason , hard provide best treatment ECMO patient . The study evaluate whether PK drug influence VA ECMO recommend optimal dosing strategy propose drug adult patient receive VA ECMO .</brief_summary>
	<brief_title>Population Pharmacokinetics Teicoplanin , Levofloxacin , Piperacillin/Tazobactam , Remifentanil , Sufentanil , Clopidogrel , Ticagrelor During Veno-arterial Extracorporeal Membrane Oxygenation ( VA ECMO )</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>patient â‰¥ 19 year old receive VA ECMO Severance Hospital , Yonsei University Health System . patient receive one drug : teicoplanin levofloxacin piperacillin/tazobactam remifentanil sufentanil clopidogrel ticagrelor patient agree participate study patient pregnant patient receive drug could affect study drug 's concentration due drugdrug interaction .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>